WHO ICTRP trial
Double-blind, randomized placebo controlled study on the effect from cortisone…
EUCTR2014-005484-32-SE · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2014-005484-32-SE |
|---|---|
| Public title | Double-blind, randomized placebo controlled study on the effect from cortisone treatment of acute loss of vestibular or balance function of the inner ear - function, subjective well-being and stress |
| Scientific title | Double-blind, randomized placebo controlled study on the effect from cortisone treatment of vestibular neuritis - function, subjective well-being and stress |
| Primary sponsor | Lund University |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Sweden |
| Conditions | Acute vestibular syndrome better known as Vestibular neuritis MedDRA version: 17.1 Level: LLT Classification code 10047392 Term: Vestibular nerve damage System Organ Class: 100000004863 MedDRA version: 17.1 Level: LLT Classification code… |
| Interventions | Trade Name: Betapred Product Name: Betapred Pharmaceutical Form: Solution for injection/infusion Pharmaceutical form of the placebo: Injection Route of administration of the placebo: Intravenous use Trade Name: Prednisolone Product Name… |
| Registration date | Mar 30, 2015 |
| Secondary IDs | VN-FT-01 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: